To determine the long-term impact reduced EMI1 expression has on CIN, clinically relevant, heterozygous knockout clones (EMI1+/−) were generated and assessed every 2 weeks over a 10-week period. Here, FBXO5 is linked to cervical squamous intraepithelial neoplasia.